Skip to main content

Table 2 Cardiovascular risk factor control and quality of life indices at baseline and 1 year

From: The women’s heart health programme: a pilot trial of sex-specific cardiovascular management

 

Control (n = 50)

Intervention (n = 50)

p-value

Body-mass-index (kg/m2)

 Baseline

26.1 (23.0-29.6)

25.7 (23.3-28.3)

0.539

 1-Year

25.2 (22.5-28.8)

23.7 (22.5-26.9)

0.318

Systolic Blood Pressure (mmHg)

 Baseline

138 (120-150)

140.5 (130-153)

0.292

 1-Year

137 (123-154)

140.0 (127-153)

0.702

Glycated Haemoglobin, Hba1C (%)

 Baseline

6.2 (5.6-6.7)

6.3 (5.7-7.4)

0.263

 1-Year

6.3 (5.6-8.2)

6.2 (5.7-6.7)

0.202

Low Density Lipoprotein (mmol/L)

 Baseline

2.5 (1.9-3.0)

2.2 (1.9-3.0)

0.712

 1-Year

2.3 (1.8-2.7)

2.4 (1.9-2.9)

0.465

High Density Lipoprotein (mmol/L)

 Baseline

1.3 (1.1-1.5)

1.3 (1.1-1.6)

0.344

 1-Year

1.2 (1.0-1.5)

1.3 (1.1-1.5)

0.369

MOS SF-36 Scores

Baseline

 Physical Component Score

51.9 (38.1-67.5)

61.3 (44.4-78.1)

0.077 *

 Mental Component Score

54.6 (31.5-81.3)

79.3 (56.0-86.3)

0.014 *

1-Year

 Physical Component Score

71.3 (48.8-83.1)

77.5 (57.5-86.3)

0.160

 Mental Component Score

79.4 (62.1-88.0)

81.0 (65.0-92.0)

0.613

Admissions (Cardiovascular)

8 (16%)

8 (16%)

0.999

All-Cause Mortality Status

2 (4%)

2 (4%)

0.999

Cardiovascular Event

5 (10%)

4 (8%)

0.727

  1. *Statistically significant at 10%